ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
GH Research PLC

GH Research PLC (GHRS)

9,04
0,23
( 2,61% )
Mis à jour : 16:21:25

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
9,04
Prix Achat
8,85
Prix Vente
9,14
Volume échangé
38 131
8,75 Fourchette du Jour 9,1499
6,00 Plage de 52 semaines 14,99
Cap du marché
Clôture Veille
8,81
Ouverture
8,97
Dernière Transaction
100
@
9.04
Dernière heure de transaction
16:21:25
Volume financier
US$ 339 171
VWAP
8,8949
Volume moyen (3 m)
75 708
Actions en circulation
52 028 145
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-13,16
Bénéfice par action (BPA)
-0,68
Chiffre d'affairess
-
Bénéfice net
-35,59M

À propos de GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Dublin, Irl
Fondé
-
GH Research PLC est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker GHRS. Le dernier cours de clôture d'GH Research était de US$8,81. Au cours de la dernière année, les actions de GH Research ont été négociées dans une fourchette de prix de US$ 6,00 à US$ 14,99.

GH Research compte actuellement 52 028 145 actions en circulation. La capitalisation boursière d'GH Research est de US$458,37 million. GH Research a un ratio cours/bénéfice (ratio PE) de -13.16.

GHRS Dernières nouvelles

GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents

Primary endpoint met in phase 2a POC trial in postpartum depression with a MADRS reduction from baseline of –35.4 points (p<0.0001, n=10) and 100% of patients in remission at Day 8Primary...

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evaluate proprietary aerosol...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.21-2.270270270279.259.338.55707998.87716799CS
41.5420.53333333337.510.236.95969528.55426706CS
120.9411.60493827168.111.096.72757088.55934315CS
26-3.56-28.25396825412.6146595118.50452287CS
521.7123.32878581177.3314.996736999.55792547CS
156-7.12-44.059405940616.1621.325.057270710.36907118CS
260-12.96-58.90909090912230.435.058130713.24730832CS

GHRS - Frequently Asked Questions (FAQ)

What is the current GH Research share price?
The current share price of GH Research is US$ 9,04
How many GH Research shares are in issue?
GH Research has 52 028 145 shares in issue
What is the market cap of GH Research?
The market capitalisation of GH Research is USD 458,37M
What is the 1 year trading range for GH Research share price?
GH Research has traded in the range of US$ 6,00 to US$ 14,99 during the past year
What is the PE ratio of GH Research?
The price to earnings ratio of GH Research is -13,16
What is the reporting currency for GH Research?
GH Research reports financial results in GBP
What is the latest annual profit for GH Research?
The latest annual profit of GH Research is GBP -35,59M
What is the registered address of GH Research?
The registered address for GH Research is 28 BAGGOT STREET LOWER, DUBLIN 2, DUBLIN, D02 NX43
What is the GH Research website address?
The website address for GH Research is www.ghres.com
Which industry sector does GH Research operate in?
GH Research operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SLXNSilexion Therapeutics Corporation
US$ 1,41
(143,10%)
129,44M
HEPAHepion Pharmaceuticals Inc
US$ 0,2717
(64,67%)
147,11M
YIBOPlanet Image International Ltd
US$ 5,024
(63,12%)
41,87M
JLJ Long Group Ltd
US$ 6,64
(48,21%)
335,32k
TRIBTrinity Biotech PLC
US$ 1,12
(47,37%)
88,93M
LPTXLeap Therapeutics Inc
US$ 0,6911
(-69,28%)
4,63M
STSSSharps Technology Inc
US$ 0,46
(-68,49%)
8,26M
SABSSAB Biotherapeutics Inc
US$ 2,2213
(-49,05%)
636,44k
MGOLMGO Global Inc
US$ 0,171
(-39,58%)
10,21M
JGAurora Mobile Ltd
US$ 10,71
(-26,29%)
1,15M
HEPAHepion Pharmaceuticals Inc
US$ 0,2703
(63,82%)
147,17M
NVDANVIDIA Corporation
US$ 119,995
(1,33%)
145,07M
SLXNSilexion Therapeutics Corporation
US$ 1,40
(141,38%)
129,53M
TRIBTrinity Biotech PLC
US$ 1,12
(47,37%)
88,93M
BACKIMAC Holdings Inc
US$ 1,1193
(35,02%)
49,62M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées